Ecstasy (MDMA) Drug Test Card 300 ng/mL | Abbott DMD-114 25/Box
Sku:DMD-114
Abbott
$48.00
/ per
In stock!
FREE SHIPPING
Spend to FREE SHIPPING
Key Features
Rapid one-step urine drug screening test
Detects Ecstasy (MDMA)
300 ng/mL screening cutoff
FDA Approved
Configured to SAMHSA screening cutoff levels
Results available in approximately 5 minutes
Easy dip-and-read procedure
Approximately 95%–98% accuracy
No special laboratory equipment required
Individually sealed test cards
25 tests per box
Suitable for professional and home use
How the Test Works
The Ecstasy (MDMA) Drug Test Card uses a lateral flow chromatographic immunoassay to detect MDMA (Ecstasy) in human urine. Simply dip the absorbent end of the test card into the urine specimen for the recommended time, then place it on a clean, flat surface while the reaction develops. Results are typically available within 5 minutes.
This test provides a preliminary analytical result only. Any preliminary positive result should be confirmed using a laboratory confirmation method such as Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS)
Package Contents
25 × Individually sealed Ecstasy (MDMA) Drug Test Cards
Instructions for Use (IFU)
Ecstasy (MDMA)
Detection Cutoff
300 ng/mL (Urine)
What is Ecstasy (MDMA)?
3,4-Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy or Molly, is a synthetic psychoactive drug that has both stimulant and hallucinogenic properties. It affects the central nervous system by increasing the release of neurotransmitters such as serotonin, dopamine, and norepinephrine, producing feelings of euphoria, emotional warmth, increased energy, and heightened sensory perception.
The Ecstasy (MDMA) Drug Test Card is designed to detect MDMA in human urine at a 300 ng/mL screening cutoff, providing fast and reliable preliminary screening results for workplace, clinical, forensic, and home drug testing programs
Medical Uses of MDMA
Although MDMA is widely recognized as an illicit recreational drug, it is currently being researched for its potential therapeutic benefits. Under carefully controlled clinical settings, MDMA-assisted therapy has shown promising results in helping treat Post-Traumatic Stress Disorder (PTSD) and is being studied for certain anxiety-related conditions.
Outside approved research and specialized medical programs, MDMA has no widely accepted routine medical use in most countries and should only be used within authorized clinical settings where permitted by local regulations
MDMA Misuse and Abuse
MDMA is commonly misused for its stimulating and mood-enhancing effects, particularly in nightlife settings such as clubs, concerts, and music festivals. Users often seek feelings of increased energy, emotional closeness, empathy, and enhanced sensory experiences. However, repeated or excessive use can have serious physical and psychological consequences.
Long-term or heavy MDMA misuse may lead to:
Anxiety and depression
Memory and concentration problems
Sleep disturbances
Increased heart rate and blood pressure
Dehydration and overheating
Mood changes and irritability
Serotonin depletion
Increased risk of overdose
Due to these risks, MDMA screening is commonly included in workplace drug testing, rehabilitation programs, healthcare facilities, and forensic investigations.
Common Effects
Increased energy
Euphoria
Enhanced mood
Emotional warmth and empathy
Heightened sensory perception
Increased heart rate
Dilated pupils
Jaw clenching
Sweating
Common Street Names
Ecstasy
Molly
E
X
XTC
Adam
Beans
Detection Window
MDMA is generally detectable in urine for 1–3 days after use. Detection times may vary depending on dosage, frequency of use, metabolism, hydration, and overall health
Conclusion
The Ecstasy (MDMA) Drug Test Card provides a fast, accurate, and convenient solution for detecting MDMA (Ecstasy) in human urine. Featuring a 300 ng/mL screening cutoff, a simple dip-and-read procedure, and results available in approximately 5 minutes, it is ideal for workplace drug screening, healthcare facilities, rehabilitation programs, and home testing. Each test card is individually packaged for single-use convenience and delivers reliable preliminary screening results without requiring specialized laboratory equipment. As with all rapid immunoassay drug screening devices, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS) before clinical, legal, or employment decisions are made.
Rapid Ecstasy (MDMA) Urine Drug Test Card
The Ecstasy (MDMA) Drug Test Card is a rapid, one-step urine drug screening test designed for the qualitative detection of 3,4-Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy or Molly, in human urine. Using a lateral flow chromatographic immunoassay, the test provides reliable preliminary screening results at a 300 ng/mL cutoff concentration without requiring specialized laboratory equipment.
This easy-to-use single-panel drug test features a simple dip-and-read procedure and delivers accurate preliminary results in approximately 5 minutes. The MDMA Drug Test Card is suitable for workplace drug testing, healthcare facilities, rehabilitation centers, educational institutions, law enforcement agencies, and home drug screening.
Each box contains 25 individually packaged test cards for convenient single-use urine drug testing.
Ecstasy (MDMA)
Drug
Typical Detection Window
Ecstasy (MDMA)
1–3 Days
Drug
Cutoff Level
Ecstasy (MDMA)
300 ng/mL
Negative Result
Two colored lines appear—one in the Control (C) region and one in the Test (T) region. Even a faint line in the Test (T) region should be interpreted as a negative result.
Preliminary Positive Result
Only one colored line appears in the Control (C) region, while no line appears in the Test (T) region. This indicates that MDMA (Ecstasy) may be present at or above the 300 ng/mL screening cutoff. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS).
Invalid Result
If no colored line appears in the Control (C) region, the test is invalid, regardless of whether a Test line appears. Repeat the test using a new test card
